Associations of NT-proBNP and hepcidin levels with clinical and laboratory parameters in patients with heart failure with various severity of left ventricular systolic dysfunction
Open Access
- 5 September 2020
- journal article
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 19 (4)
- https://doi.org/10.15829/1728-8800-2020-2587
Abstract
Data on hepcidin levels in patients with heart failure (HF) are contradictory and do not make clear its contribution to the progression of multiple organ failure. There remain a number of issues about the prognostic significance of the N-terminal pro-brain natriuretic peptide (NT-proBNP) in HF with preserved ejection fraction (EF). The authors suggested the relationships between these markers in decompensated HF, as well as their associations with other clinical and laboratory parameters.Aim. To identify the association of NT-proBNP and hepcidin levels with clinical and laboratory parameters in patients with HF with various severity of left ventricular (LV) systolic dysfunction.Material and methods. The study included 68 patients (29 women, 39 men; mean age — 72,3±11,7 years) hospitalized due to decompensated HF. Patients were divided into three groups: reduced (HFrEF) (n=20), mid-range (HFmrEF) (n=23), and preserved EF (HFpEF) (n=24). Upon admission, along with standard diagnostic tests, all patients were examined for NT-proBNP and hepcidin levels by enzyme-linked immunosorbent assay. Statistical processing was carried out using the software package Statistica 8.0.Results. NT-proBNP levels in the entire sample was 315,9 [129,9; 576,1] pg/ml. Significantly higher concentrations of NT-proBNP were found in patients with lower EF: 433,05 (346,8-892,6) pg/ml for HFrEF, 289,97 (185,9-345,3) pg/ml for HFmrEF pg/ml and 214,98 (207,37-562,31) pg/ ml for HFpEF (pConclusion. Patients with lower EF showed higher NT-proBNP values and a trend towards higher hepcidin levels. Relationships of hepcidin and NT-proBNP levels with following clinical parameters were found: body mass index, presence of obstructive airway diseases, cardiac arrhythmias, as well as low cardiac output syndrome, cardiorenal syndrome and anemia.Keywords
This publication has 17 references indexed in Scilit:
- Hepcidin regulation in the anemia of inflammationCurrent Opinion in Hematology, 2016
- Serum adipokines might predict liver histology findings in non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology, 2016
- Liver Congestion in Heart Failure Contributes to Inappropriately Increased Serum Hepcidin despite AnemiaThe Tohoku Journal of Experimental Medicine, 2015
- Serum hepcidin levels are associated with obesity but not liver diseaseObesity, 2013
- Iron status in patients with chronic heart failureEuropean Heart Journal, 2012
- Hepcidin and iron homeostasisBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2012
- Hepcidin in anemia of chronic heart failureAmerican Journal of Hematology, 2010
- State of the art: Using natriuretic peptide levels in clinical practiceEuropean Journal of Heart Failure, 2008
- Systemic Effects of Chronic Obstructive Pulmonary DiseaseProceedings of the American Thoracic Society, 2005
- The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: Results of the UK natriuretic peptide studyEuropean Journal of Heart Failure, 2005